Abcam (ABC) Stock Rating Reaffirmed by Peel Hunt

Share on StockTwits

Abcam (LON:ABC)‘s stock had its “hold” rating reiterated by investment analysts at Peel Hunt in a research note issued to investors on Thursday.

A number of other equities analysts have also commented on ABC. Berenberg Bank reiterated a “hold” rating and set a GBX 1,230 ($16.07) price target on shares of Abcam in a report on Thursday, July 12th. Numis Securities reiterated a “hold” rating and set a GBX 1,380 ($18.03) price target on shares of Abcam in a report on Thursday, July 12th.

Shares of LON:ABC opened at GBX 1,200 ($15.68) on Thursday. Abcam has a 52 week low of GBX 9.73 ($0.13) and a 52 week high of GBX 1,290 ($16.86).

In related news, insider Jonathan Simon Milner sold 1,000,000 shares of Abcam stock in a transaction on Friday, September 28th. The shares were sold at an average price of GBX 1,441 ($18.83), for a total transaction of £14,410,000 ($18,829,217.30). Also, insider Peter Allen bought 12,000 shares of the stock in a transaction that occurred on Thursday, September 13th. The shares were purchased at an average cost of GBX 1,304 ($17.04) per share, with a total value of £156,480 ($204,468.84).

Abcam Company Profile

Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays.

Recommended Story: What is a stock buyback?

Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply